Mushroom management indeed.
Surprised that didn't even move the share price, interesting.
Any chance anybody on here has a Bloomberg Law subscription to access this article?
https://news.bloomberglaw.com/health-law-and-business/mithra-says-fda-asks-for-more-data-on-myring-compatibility
I sent an irate email to our esteemed investor relations and communications VP....
"Hi Lisa,
Long term shareholder here.
The ASX Announcement today is unsatisfactory in the information it provided.
Can you please specify the exact reasons approval was withheld / what questions were raised by the FDA.
Scott stated everything that it wasn't.... are we supposed to work out what it is?
Please state explicitly what exactly the questions was in relation to and what they were.
None of this mushroom management.
This product should have been approved a long time ago already.
"
Sent more as a joke.
I don't actually expect a proper answer....
(20min delay)